Tarique Shahzad Chachar: Why Warfarin Remains the Gold Standard for Mechanical Heart Valves
Tarique Shahzad Chachar, Senior Clinical Educator at Bahrain Defence Force, Royal Medical Services (MKCC), shared a post on LinkedIn:
“Warfarin remains a cornerstone of anticoagulation in patients with atrial fibrillation who have mechanical prosthetic heart valves.
While DOACs are preferred for most patients with non-valvular AF, mechanical valve patients require vitamin K antagonist therapy with warfarin because DOACs are not recommended in this setting.
Key principles include maintaining the appropriate INR target according to valve type, valve position, and thromboembolic risk factors, regular INR monitoring, reviewing drug and dietary interactions, and promptly managing supratherapeutic INR or bleeding.
For mechanical valves, effective anticoagulation requires a careful balance between preventing valve thrombosis and systemic embolism while minimizing bleeding risk.
Right patient.
Right INR.
Right monitoring.
Safer outcomes.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?